PUBLICATION

The possible repositioning of an oral anti-arthritic drug, auranofin, for Nrf2-activating therapy: the demonstration of Nrf2-dependent anti-oxidative action using a zebrafish model

Authors
Fuse, Y., Endo, Y., Araoi, S., Daitoku, H., Suzuki, H., Kato, M., Kobayashi, M.
ID
ZDB-PUB-171227-1
Date
2017
Source
Free radical biology & medicine   115: 405-411 (Journal)
Registered Authors
Endo, Yuka, Fuse, Yuji, Kobayashi, Makoto
Keywords
Nrf2 pathway, arsenite toxicity, auranofin-induced protection, heavy metal, oxidative stress, zebrafish genetics
MeSH Terms
  • Zebrafish
  • Zebrafish Proteins/antagonists & inhibitors*
  • Zebrafish Proteins/genetics
  • Arthritis/drug therapy*
  • Organisms, Genetically Modified
  • Oxidation-Reduction
  • Antirheumatic Agents/pharmacology
  • Antirheumatic Agents/therapeutic use*
  • Drug Repositioning
  • Animals
  • Metals, Heavy/toxicity
  • Antioxidants/pharmacology
  • Antioxidants/therapeutic use*
  • Administration, Oral
  • Larva
  • Mutation/genetics
  • Oxidative Stress/drug effects
  • Disease Models, Animal
  • Humans
  • NF-E2-Related Factor 2/antagonists & inhibitors*
  • NF-E2-Related Factor 2/genetics
  • Signal Transduction
  • Hydrogen Peroxide/toxicity
  • Arsenites/toxicity
  • Auranofin/pharmacology
  • Auranofin/therapeutic use*
(all 26)
PubMed
29277393 Full text @ Free Radic. Biol. Med.
Abstract
The Nrf2 pathway is a biological defense system against oxidative stress. The pharmacological activation of the Nrf2 pathway is a promising therapy for oxidative stress-related diseases, but it has been challenging to find an Nrf2 activator with acceptable toxicity. To circumvent this problem, we focused on an already approved oral anti-arthritic drug, auranofin that has been reported to have the potential to activate Nrf2. We used a zebrafish model to investigate whether auranofin has protective action against oxidative stress in vivo. Auranofin pre-treatment considerably improved the survival of zebrafish larvae that were challenged with a lethal dose of hydrogen peroxide. This protective effect was not observed in an Nrf2 mutant zebrafish strain, suggesting that the activation of the biological defense against oxidative stress was Nrf2-dependent. Auranofin-induced protection was further tested by challenges with redox-active heavy metals. A clear protective effect was observed against arsenite, a highly redox-reactive toxicant. In addition, this effect was also demonstrated to be Nrf2-dependent based on the analysis of an Nrf2 mutant strain. These results clearly demonstrate the anti-oxidative action of auranofin and encourage the repositioning of auranofin as a drug that improves oxidative stress-related pathology.
Genes / Markers
Figures
No images available
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Citation
Fuse, Y., Endo, Y., Araoi, S., Daitoku, H., Suzuki, H., Kato, M., Kobayashi, M. (2017) The possible repositioning of an oral anti-arthritic drug, auranofin, for Nrf2-activating therapy: the demonstration of Nrf2-dependent anti-oxidative action using a zebrafish model. Free radical biology & medicine. 115:405-411.